日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Synergistic effect of FMS-like tyrosine kinase-3 (FLT3) inhibitors combined with a CDK7 inhibitor in FLT3-ITD-mutated acute myeloid leukemia

FMS样酪氨酸激酶-3 (FLT3) 抑制剂与CDK7抑制剂联合治疗FLT3-ITD突变型急性髓系白血病的协同作用

Koo, Bon-Kwan; Choi, Eun-Ji; Moon, Ju Hyun; Kim, Ji Yun; Park, Hyunkyung; Park, Han-Seung; Choi, Yunsuk; Lee, Jung-Hee; Lee, Kyoo-Hyung; Choi, Eun Kyung; Kim, Eunji; Lee, Je-Hwan; Hur, Eun-Hye

Inhibition of DNMT3B and PI3K/AKT/mTOR and ERK Pathways as a Novel Mechanism of Volasertib on Hypomethylating Agent-Resistant Cells

抑制 DNMT3B 和 PI3K/AKT/mTOR 及 ERK 通路是 Volasertib 治疗低甲基化剂耐药细胞的新机制

Eun-Ji Choi, Bon-Kwan Koo, Eun-Hye Hur, Ju Hyun Moon, Ji Yun Kim, Han-Seung Park, Yunsuk Choi, Kyoo-Hyung Lee, Jung-Hee Lee, Eun Kyung Choi, Je-Hwan Lee

Antileukemic activity of YPN-005, a CDK7 inhibitor, inducing apoptosis through c-MYC and FLT3 suppression in acute myeloid leukemia

YPN-005(一种 CDK7 抑制剂)的抗白血病活性,通过抑制 c-MYC 和 FLT3 诱导急性髓系白血病细胞凋亡

Bon-Kwan Koo, Eun-Ji Choi, Eun-Hye Hur, Ju Hyun Moon, Ji Yun Kim, Han-Seung Park, Yunsuk Choi, Jung-Hee Lee, Kyoo-Hyung Lee, Eun Kyung Choi, Jinhwan Kim, Je-Hwan Lee

Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome

韩国骨髓增生异常综合征患者中microRNA的表达及其预后意义

Choi, Yunsuk; Hur, Eun-Hye; Moon, Ju Hyun; Goo, Bon-Kwan; Choi, Dae Ro; Lee, Je-Hwan

Establishment and characterization of hypomethylating agent-resistant cell lines, MOLM/AZA-1 and MOLM/DEC-5

低甲基化剂耐药细胞系 MOLM/AZA-1 和 MOLM/DEC-5 的建立和表征

Eun-Hye Hur, Seung-Hyun Jung, Bon-Kwan Goo, Juhyun Moon, Yunsuk Choi, Dae Ro Choi, Yeun-Jun Chung, Je-Hwan Lee